BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34768)

  • 1. Chronic haloperidol: tolerance to the stimulating effect on striatal tyrosine hydroxylase.
    Tissari AH; Casu M; Gessa GL
    Life Sci; 1979 Jan; 24(5):411-6. PubMed ID: 34768
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of haloperidol-mediated effects on rat striatal tyrosine hydroxylase.
    Pradhan S; Alphs L; Lovenberg W
    Neuropharmacology; 1981 Feb; 20(2):149-54. PubMed ID: 6111042
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term haloperidol treatment and factors affecting the activity of striatal tyrosine hydroxylase.
    Lovenberg W; Alphs L; Pradhan S; Bruckwick E; Levine R
    Adv Biochem Psychopharmacol; 1980; 24():9-15. PubMed ID: 6105810
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulation of the kinetic state of striatal tyrosine hydroxylase and the role of postsynaptic dopamine receptors.
    Zivkovic B; Guidotti A; Costa E
    Brain Res; 1975 Jul; 92(3):516-21. PubMed ID: 240486
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
    Kapatos G; Zigmond MJ
    J Pharmacol Exp Ther; 1979 Mar; 208(3):468-75. PubMed ID: 34711
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptics-induced changes of tyrosine hydroxylase activity in rat striatum in vitro and in vivo.
    Honma T; Hirose A
    Life Sci; 1979 May; 24(22):2023-30. PubMed ID: 37397
    [No Abstract]   [Full Text] [Related]  

  • 8. The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.
    Zivkovic B; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):193-200. PubMed ID: 629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to tyrosine hydroxylase activation in n. accumbens and c. striatum after repeated injections of "classical" and "atypical" antischizophrenic drugs.
    Guidotti A; Gale K; Toffano G; Vargas FM
    Life Sci; 1978 Aug; 23(5):501-5. PubMed ID: 29190
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 11. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G; Onali PL; Tissari AH; Porceddu ML; Morelli M; Gessa GL
    Life Sci; 1978 Aug; 23(7):691-6. PubMed ID: 29204
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J; Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):367-9. PubMed ID: 4152779
    [No Abstract]   [Full Text] [Related]  

  • 13. Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity.
    Gale K; Moroni F; Kumakura K; Guidotti A
    Neuropharmacology; 1979 Apr; 18(4):427-30. PubMed ID: 36574
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic agonist and antagonist effects on striatal tyrosine hydroxylase distribution.
    Smith CP; Ellis DB; Meyerson LR
    Life Sci; 1981 Jan; 28(2):193-7. PubMed ID: 6114374
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL; Grewaal DS; McGeer EG
    Brain Res; 1974 Nov; 80(2):211-7. PubMed ID: 4154064
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation and inactivation of striatal tyrosine hydroxylase: the effects of pH, ATP and cyclic AMP, S-adenosylmethionine and S-adenosylhomocysteine.
    Mann SP; Hill MW
    Biochem Pharmacol; 1983 Nov; 32(22):3369-74. PubMed ID: 6140010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of tyrosine hydroxylase after chronic treatment with classic and atypical antischizophrenic drugs.
    Guidotti A
    Adv Biochem Psychopharmacol; 1980; 24():1-8. PubMed ID: 6105767
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of l-stepholidine on tyrosine hydroxylase activity in rat corpus striatum.
    Guo X; Chen LJ; Buda M; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):289-92. PubMed ID: 1360740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain tyrosine level controls striatal dopamine synthesis in haloperidol-treated rats.
    Scally MC; Ulus I; Wurtman RJ
    J Neural Transm; 1977; 41(1):1-6. PubMed ID: 21228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.